ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $387,000 | +200.0% | 372,557 | +115.9% | 0.24% | +98.4% |
| Q4 2018 | $129,000 | -48.8% | 172,557 | +45.4% | 0.12% | -25.2% |
| Q3 2018 | $252,000 | +10.5% | 118,689 | +20.3% | 0.16% | +5.2% |
| Q2 2018 | $228,000 | -27.4% | 98,689 | 0.0% | 0.16% | -25.1% |
| Q1 2018 | $314,000 | +166.1% | 98,689 | +244.0% | 0.21% | +200.0% |
| Q4 2017 | $118,000 | -9.2% | 28,689 | 0.0% | 0.07% | +3.0% |
| Q3 2017 | $130,000 | +35.4% | 28,689 | 0.0% | 0.07% | +31.4% |
| Q2 2017 | $96,000 | -69.9% | 28,689 | -17.3% | 0.05% | -71.2% |
| Q1 2017 | $319,000 | -41.5% | 34,689 | -50.9% | 0.18% | -47.2% |
| Q4 2016 | $545,000 | -32.5% | 70,689 | 0.0% | 0.34% | -29.0% |
| Q3 2016 | $808,000 | -7.1% | 70,689 | 0.0% | 0.47% | -25.3% |
| Q2 2016 | $870,000 | +21.7% | 70,689 | 0.0% | 0.63% | +23.9% |
| Q1 2016 | $715,000 | -46.0% | 70,689 | +20.4% | 0.51% | -33.1% |
| Q4 2015 | $1,323,000 | +35.8% | 58,689 | 0.0% | 0.76% | +21.5% |
| Q3 2015 | $974,000 | -26.3% | 58,689 | 0.0% | 0.63% | -10.2% |
| Q2 2015 | $1,321,000 | +14.7% | 58,689 | +31.3% | 0.70% | +15.4% |
| Q1 2015 | $1,152,000 | +135.6% | 44,689 | +98.7% | 0.60% | +113.0% |
| Q4 2014 | $489,000 | – | 22,489 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|